Solara Active Pharma Sciences Limited has informed the exchange regarding the conference call scheduled with the investors and analysts on Thursday, May 15, 2025 at 3:30 PM to discuss the Company's Financial results for the quarter and year ended March 31, 2025
SOLARA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Solara Active Pharma Sciences has informed the exchanges that it will hold a conference call with investors and analysts on Thursday, May 15, 2025 at 3:30 PM IST. The call is scheduled to discuss the company's financial results for the quarter and full year ended March 31, 2025 (Q4 FY25 and FY25). The call will be attended by Founder & Non-Executive Director Arun Kumar, MD & CEO Sandeep Rao, and CFO Sarat Kumar. Dial-in numbers and an early registration DiamondPass link have been provided to participants. The intimation has been filed under SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
This is a routine post-results investor engagement activity. The call gives analysts and institutional investors direct access to management, which often helps shape near-term market expectations and analyst commentary around the stock following the FY25 earnings release.